Novartis Pharma Stein AG (manufacturing, quality control, primary packaging, secondary packaging, batch release)

The drug is used for the prevention of transplant rejection in adult patients with low to moderate immunological risk following kidney or heart transplantation. It should be used in combination with cyclosporine and corticosteroids.

Dosage form: tablets

ATC: L04AA18